Brian Goff

2017

In 2017, Brian Goff earned a total compensation of $4.1M as Executive Vice President and Chief Commercial Officer at Alexion Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$434,380
Option Awards$732,899
Salary$381,634
Stock Awards$2,390,026
Other$58,787
Total$4,097,726

Goff received $2.4M in stock awards, accounting for 58% of the total pay in 2017.

Goff also received $100K in bonus, $434.4K in non-equity incentive plan, $732.9K in option awards, $381.6K in salary and $58.8K in other compensation.

Rankings

In 2017, Brian Goff's compensation ranked 2,494th out of 14,666 executives tracked by ExecPay. In other words, Goff earned more than 83.0% of executives.

ClassificationRankingPercentile
All
2,494
out of 14,666
83rd
Division
Manufacturing
869
out of 5,772
85th
Major group
Chemicals And Allied Products
228
out of 2,075
89th
Industry group
Drugs
175
out of 1,731
90th
Industry
Pharmaceutical Preparations
140
out of 1,333
90th
Source: SEC filing on March 26, 2019.

Goff's colleagues

We found five more compensation records of executives who worked with Brian Goff at Alexion Pharmaceuticals in 2017.

2017

Ludwig Hantson

Alexion Pharmaceuticals

Chief Executive Officer

2017

Paul Clancy

Alexion Pharmaceuticals

Chief Financial Officer

2017

Julie O'Neill

Alexion Pharmaceuticals

Former Executive Vice President of Global Operations

2017

John Orloff

Alexion Pharmaceuticals

Executive Vice President, Head of Research & Development

2017

Anne-Marie Law

Alexion Pharmaceuticals

Executive Vice President, Chief Patient and Employee Experience Officer

News

You may also like